![(2S)-2-azanyl-N-[(2S)-1-azanylidene-3-(4-phenylphenyl)propan-2-yl]butanamide in PDB entry 4cdc, assembly 2, side view.](https://www.ebi.ac.uk/pdbe/static/entry/4cdc_entity_5_side_image-200x200.png "Hetero trimeric assembly 2 of PDB entry <span class='highlight'>4cdc</span> contains 1 copy of <span class='highlight'>(2S)-2-azanyl-N-[(2S)-1-azanylidene-3-(4-phenylphenyl)propan-2-yl]butanamide</span>. Side view.")
![(2S)-2-azanyl-N-[(2S)-1-azanylidene-3-(4-phenylphenyl)propan-2-yl]butanamide in PDB entry 4cdc, assembly 2, top view.](https://www.ebi.ac.uk/pdbe/static/entry/4cdc_entity_5_top_image-200x200.png "Hetero trimeric assembly 2 of PDB entry <span class='highlight'>4cdc</span> contains 1 copy of <span class='highlight'>(2S)-2-azanyl-N-[(2S)-1-azanylidene-3-(4-phenylphenyl)propan-2-yl]butanamide</span>. Top view.")
Environment details NEW
6AO 1368 bound to chain E
The above 2D and 3D (Mol*) views of ligand interactions use quaternary structure derived from the PDB entry.
Please note:
Please note:
- Some chain IDs in the tooltip are followed by a number in square brackets. This number corresponds to the operation ID (mmCIF ‘oper_expression’) used to transform the chain.
- The structure seen in Mol* (3D view) was protonated using ChimeraX.
- Interactions were calculated using Arpeggio (see details for interaction types).
- The colour scheme used is consistent with Clustal X.